Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.140
-0.060 (-2.73%)
Mar 31, 2025, 9:30 AM EST - Market open

Perspective Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Jun '22 Jun '21 2020 - 2016
Revenue
1.451.435.42-10.05
Upgrade
Revenue Growth (YoY)
1.40%-73.52%--3.85%
Upgrade
Cost of Revenue
39.4320.343.05-4.93
Upgrade
Gross Profit
-37.98-18.912.37-5.12
Upgrade
Selling, General & Admin
26.6121.069.355.577.13
Upgrade
Research & Development
2.210.971.810.851.43
Upgrade
Operating Expenses
28.8222.0311.176.428.56
Upgrade
Operating Income
-66.8-40.94-8.8-6.42-3.44
Upgrade
Interest Expense
-0.05-0.08---
Upgrade
Interest & Investment Income
10.520.930.620.120.06
Upgrade
Earnings From Equity Investments
-0.01-0.02---
Upgrade
EBT Excluding Unusual Items
-56.34-40.11-8.18-6.3-3.38
Upgrade
Impairment of Goodwill
-24.06----
Upgrade
Gain (Loss) on Sale of Assets
-0.03--0.31--0.01
Upgrade
Pretax Income
-80.43-40.11-8.49-6.3-3.39
Upgrade
Income Tax Expense
-2.1-2.65---
Upgrade
Earnings From Continuing Operations
-78.33-37.46-8.49-6.3-3.39
Upgrade
Earnings From Discontinued Operations
-0.95-9.05-2.28-0.97-
Upgrade
Net Income
-79.28-46.51-10.76-7.27-3.39
Upgrade
Preferred Dividends & Other Adjustments
----0
Upgrade
Net Income to Common
-79.28-46.51-10.76-7.27-3.39
Upgrade
Shares Outstanding (Basic)
6427141410
Upgrade
Shares Outstanding (Diluted)
6427141410
Upgrade
Shares Change (YoY)
140.72%88.38%0.06%36.73%53.61%
Upgrade
EPS (Basic)
-1.23-1.74-0.76-0.51-0.33
Upgrade
EPS (Diluted)
-1.23-1.74-0.76-0.51-0.33
Upgrade
Free Cash Flow
-72.71-37.99-10.68-7.98-3.22
Upgrade
Free Cash Flow Per Share
-1.13-1.42-0.75-0.56-0.31
Upgrade
Gross Margin
--43.71%-50.94%
Upgrade
Operating Margin
-4594.02%-2855.02%-162.47%--34.19%
Upgrade
Profit Margin
-5452.48%-3243.24%-198.71%--33.72%
Upgrade
Free Cash Flow Margin
-5000.55%-2648.88%-197.28%--32.01%
Upgrade
EBITDA
-64.5-40.23-8.48-6.14-3.23
Upgrade
EBITDA Margin
---156.56%--32.10%
Upgrade
D&A For EBITDA
2.30.710.320.280.21
Upgrade
EBIT
-66.8-40.94-8.8-6.42-3.44
Upgrade
EBIT Margin
---162.47%--34.19%
Upgrade
Revenue as Reported
--5.42--
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q